Thousands of Americans are diagnosed with Type 1 diabetes every year, according to the American Diabetes Association. But a new medication now available worldwide has the potential to drive that ...

Epinephrine should be prescribed for anyone who has ever had an anaphylactic attack and for infants and children at high risk ...

A new report card has found that American children average a D- when it comes to the recommended daily dose of physical activity.

Learn more about Mucinex, a popular over-the-counter cough medication, including how it works, how long it lasts, and safety ...

Haleon (Canada), a global leader in consumer health, announced today a donation of over 280,000 bottles of Children's Advil to two Canadian-based, non-profit organizations. This donation supports ...

Golisano Children's Hospital has earned recognition as one of the nation's best children's hospitals in three specialty ...

Tylenol should only be given to children under 2 with the approval ... as long as you make sure not to go over the recommended daily dosage of each. One example of a combination medication includes ...

Unless you're instructed otherwise by a medical provider, adults can take 200 to 400 milligrams of ibuprofen every four to six hours (per Mayo Clinic). (Talk to your pediatrician if you need dosing ...

In the study, men and women over 40 with knee osteoarthritis took capsules containing castor oil or diclofenac sodium (a nonsteroidal anti-inflammatory drug) three times daily ... before giving castor ...

A recent study shows 10 to 20% of children may have developed long Covid following an acute infection. A new study is testing ...

This is Atlantic Intelligence, a newsletter in which our writers help you wrap your mind around artificial intelligence and a new machine age. Sign up here. A disaster is brewing on dark-web ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach. By Ellen Barry and Christina Jewett The Food and Drug Administration on ...